(Q30956012)

27 June 2017

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort (English)

1 reference

systemic lupus erythematosus

27 June 2017

1 reference

1 reference

Mikdashi J

1

1 reference

PubMed ID

15342927

27 June 2017

Handwerger B

series ordinal

2

1 reference

27 June 2017

1 September 2004

1 reference

27 June 2017

1 reference

27 June 2017

43

1 reference

27 June 2017

12

1 reference

27 June 2017

1555-1560

1 reference

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes

27 June 2017

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

International Society on Antiphospholipid Antibodies, Tours, France, 12-16 September 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Lowering anti-dsDNA antibodies--what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Ribosomal P antibodies and CNS lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH384

10.1093/RHEUMATOLOGY/KEH384

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference

PubMed ID

15342927